HeartSciences annual meeting approves director, stock plan, auditor; officer exculpation fails

HeartSciences Inc.

Andrew Simpson re-elected Class III director with 577,840 for, 107,738 withheld, 1,288,285 broker non-votes.
Amendment to 2023 Employee Stock Purchase Plan approved, increasing reserved shares to 1,250,000.
Proposal to amend certificate of formation for officer exculpation under Texas law did not pass; needed majority of outstanding shares.
Haskell & White LLP ratified as independent auditor for FY2026 with 1,872,912 votes for.
Adjournment proposal approved (1,784,662 for) to allow further proxy solicitation if needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.